Literature DB >> 9714440

Paternal inheritance or different mutations in maternally related patients occur in about 3% of Duchenne familial cases.

M Zatz1, D Sumita, S Campiotto, M Canovas, A Cerqueira, M Vainzof, M R Passos-Bueno.   

Abstract

Duchenne dystrophy (DMD) is an X-linked lethal condition which affects 1 in 3,500 boys. The DMD gene is deleted in about 60-65% of patients while in the remaining 35-40% the condition is caused by point mutations, small insertions, or duplications. We have ascertained 967 DMD families (680 isolated and 287 familial cases). Screening for deletions showed a molecular deletion in 383 among 615 (62.3%) analyzed cases. However, 10 families were unusual: In 7 of them, 2 or more DMD patients were related through paternal lines while in 3 others, affected boys related through maternal lines carried different mutations or originated through independent new mutation events. The finding of 10 atypical genealogies, which represent about 1% of the sample (10/967) or about 3% of familial cases (10/287) is higher than we would expect by chance. Even so, it is an underestimate because screening of mutations in all the affected DMD relatives from each genealogy is not done in many of the familial cases. It suggests that other mechanisms (such as transposon-like elements, for example) could be responsible for a higher genomic instability leading to novel mutations as reported previously by us and others in DMD and in other genetic disorders such as hemophilia and inherited peripheral neuropathies. On the other hand, it shows the importance of testing all affected patients within each genealogy to prevent possible mistakes in carrier detection, genetic counseling, and prenatal diagnosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714440     DOI: 10.1002/(sici)1096-8628(19980724)78:4<361::aid-ajmg11>3.0.co;2-g

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  4 in total

1.  Two sisters with Rett syndrome and non-identical paternally-derived microdeletions in the MECP2 gene.

Authors:  Lyndon G Rosser; Shane McKee; David S Millar; Hayley Archer; James Hughes; Rachel Butler; Nadia Chuzhanova; David N Cooper; Lazarus P Lazarou
Journal:  Genomic Med       Date:  2008-09-20

2.  Intra-individual plasticity of the TAZ gene leading to different heritable mutations in siblings with Barth syndrome.

Authors:  Lorenzo Ferri; Maria A Donati; Silvia Funghini; Catia Cavicchi; Viviana Pensato; Cinzia Gellera; Federica Natacci; Luigina Spaccini; Serena Gasperini; Frédéric M Vaz; David N Cooper; Renzo Guerrini; Amelia Morrone
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

3.  Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion.

Authors:  Q L Lu; G E Morris; S D Wilton; T Ly; O V Artem'yeva; P Strong; T A Partridge
Journal:  J Cell Biol       Date:  2000-03-06       Impact factor: 10.539

4.  EMQN best practice guidelines for genetic testing in dystrophinopathies.

Authors:  Carl Fratter; Raymond Dalgleish; Stephanie K Allen; Rosário Santos; Stephen Abbs; Sylvie Tuffery-Giraud; Alessandra Ferlini
Journal:  Eur J Hum Genet       Date:  2020-05-18       Impact factor: 4.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.